bf/NASDAQ:PSTI_icon.jpeg

NASDAQ:PSTI

Pluristem Therapeutics Inc.

  • Stock

USD

Last Close

1.03

26/07 04:00

Market Cap

40.85M

Beta: 1.91

Volume Today

170.63K

Avg: -

PE Ratio

−0.56

PFCF: −1.31

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
net income
-26.93M
-
-24.68M
8.37%
-23.25M
5.80%
-27.81M
19.65%
-26.13M
6.07%
-35.31M
35.14%
-29.15M
17.43%
-49.87M
71.05%
depreciation and amortization
1.90M
-
2.07M
9.04%
2.15M
3.66%
2.18M
1.26%
2.02M
7.30%
1.96M
2.78%
1.57M
19.98%
1.37M
12.74%
deferred income tax
stock based compensation
5.85M
-
4.05M
30.75%
3.07M
24.16%
3.66M
19.17%
6.55M
78.81%
5.15M
21.41%
2.56M
50.21%
13.97M
445.20%
change in working capital
-594K
-
-2.63M
342.93%
-921K
64.99%
-134K
85.45%
3.75M
2,897.01%
-1.25M
133.38%
-1.34M
6.95%
3.67M
373.92%
accounts receivables
-1.99M
-
572K
128.74%
-537K
193.88%
1.19M
321.97%
978K
17.95%
-121K
112.37%
37K
130.58%
inventory
664K
-
-2.10M
416.87%
2.63M
225.14%
-24.23M
1,020.13%
-21.93M
9.48%
-18.48M
15.73%
-789K
95.73%
accounts payables
1.26M
-
-566K
145.03%
-77K
86.40%
-701K
810.39%
1.21M
272.90%
-863K
171.20%
-291K
66.28%
578K
298.63%
other working capital
-525K
-
-533K
1.52%
-2.94M
451.59%
23.60M
902.79%
23.49M
0.48%
18.21M
22.46%
-295K
101.62%
3.09M
1,146.44%
other non cash items
652K
-
577K
11.50%
422K
26.86%
498K
18.01%
-7.57M
1,619.68%
-3K
99.96%
-11K
266.67%
-48K
336.36%
net cash provided by operating activities
-19.12M
-
-20.61M
7.76%
-18.52M
10.11%
-21.61M
16.68%
-21.38M
1.07%
-29.45M
37.76%
-26.37M
10.47%
-30.91M
17.22%
investments in property plant and equipment
-1.57M
-
-831K
47.17%
-1.75M
110.59%
-378K
78.40%
-342K
9.52%
-239K
30.12%
-270K
12.97%
-373K
38.15%
acquisitions net
purchases of investments
-10.85M
-
-4.90M
54.83%
-5.06M
3.28%
-3.61M
28.77%
-15.97M
342.89%
-30.19M
-
sales maturities of investments
14.29M
-
27.33M
91.28%
8.09M
70.39%
8.25M
1.98%
21.89M
165.24%
1.42M
93.54%
other investing activites
122K
-
-59K
148.36%
33K
155.93%
30K
9.09%
-6K
-
-6.89M
-
net cash used for investing activites
1.98M
-
21.54M
986.08%
1.31M
93.91%
4.30M
227.59%
5.57M
29.66%
1.17M
79.01%
-30.46M
2,703.25%
-7.26M
76.15%
debt repayment
common stock issued
10.64M
-
16.91M
58.91%
790K
95.33%
15.72M
1,889.62%
18.63M
18.53%
23.47M
25.96%
58.16M
147.85%
36.59M
37.09%
common stock repurchased
dividends paid
other financing activites
1.98M
-
287K
85.51%
17K
94.08%
79K
364.71%
1.29M
1,532.91%
115K
91.09%
2.71M
2,253.91%
24.81M
816.62%
net cash used provided by financing activities
12.62M
-
17.20M
36.26%
807K
95.31%
15.80M
1,857.50%
19.92M
26.11%
23.58M
18.38%
60.87M
158.12%
61.40M
0.87%
effect of forex changes on cash
-618K
-
net change in cash
-4.51M
-
18.13M
501.71%
-16.40M
190.46%
-1.52M
90.76%
4.11M
371.37%
-4.70M
214.27%
4.04M
186.00%
22.61M
459.21%
cash at beginning of period
9.01M
-
4.49M
50.12%
22.63M
403.58%
6.22M
72.50%
4.71M
24.36%
9.89M
110.05%
5.19M
47.55%
9.23M
77.96%
cash at end of period
4.49M
-
22.63M
403.58%
6.22M
72.50%
4.71M
24.36%
8.82M
87.40%
5.19M
41.21%
9.23M
77.96%
31.84M
244.98%
operating cash flow
-19.12M
-
-20.61M
7.76%
-18.52M
10.11%
-21.61M
16.68%
-21.38M
1.07%
-29.45M
37.76%
-26.37M
10.47%
-30.91M
17.22%
capital expenditure
-1.57M
-
-831K
47.17%
-1.75M
110.59%
-378K
78.40%
-342K
9.52%
-239K
30.12%
-270K
12.97%
-373K
38.15%
free cash flow
-20.69M
-
-21.44M
3.59%
-20.27M
5.43%
-21.99M
8.47%
-21.72M
1.21%
-29.69M
36.69%
-26.64M
10.28%
-31.28M
17.43%

All numbers in USD (except ratios and percentages)